Federal prosecutors have filed a civil lawsuit accusing two former executives of an Atlanta-area clinical laboratory of orchestrating a Medicare scheme that funneled roughly $13.7 million in payments for genetic and respiratory pathogen tests that patients' doctors never ordered. The complaint targets Jay Johnson, the former CEO and chief operating officer of Capstone Diagnostics, and Austin Whiles, the company's former chief sales officer and vice president of business development, along with several related businesses.
According to the civil complaint in intervention filed by the U.S. Department of Justice on September 17, 2026, Johnson and Whiles arranged for people attending church health fairs and religious conferences to be swabbed for large genetic testing panels that their own doctors had never requested. As reported by FOX 5 Atlanta, the alleged tests took place between 2019 and 2021, with Johnson allegedly directing Capstone employees to use doctors' names, signatures, and standing orders without permission to make the tests appear properly ordered and medically necessary.
Kickbacks and Copied Signatures
The lawsuit alleges Johnson and Whiles paid kickbacks to conference organizers and independent marketers who generated testing business for the lab. Capstone also allegedly added broad respiratory pathogen panels onto COVID-19 tests requested by senior living communities, relying on communitywide standing orders rather than individualized medical judgment, per the same DOJ filing.
The station's report notes that Capstone allowed sales employees — not treating providers — to enter medical orders, and that the company used copied doctors' signatures and standardized diagnosis codes to push claims through. Federal officials said laboratory testing should be based on patients' medical needs rather than the amount of money a company can collect, according to the DOJ complaint.
Millions Allegedly Diverted to Family and Shell Companies
Beyond the primary defendants, the DOJ's complaint in intervention seeks to claw back funds from additional individuals and entities it says benefited from the scheme. Federal prosecutors allege Johnson transferred millions of dollars from the scheme to his former wife, Sarah Haslock, while the government is also pursuing unjust enrichment claims against corporate entities Why Not Productions LLC and Whitson Medical, Inc.
Whiles, meanwhile, is accused of routing approximately $4.75 million in volume-based sales commissions from independent marketers into his personal corporate entity, Whitson Medical, Inc., which dissolved in 2025, per the DOJ complaint. Capstone's third-party billing company, VitalAxis Inc., separately agreed to pay $300,479 to resolve its own potential civil liability under the False Claims Act for processing the improper lab claims, the department said.
Origins in a 2024 Whistleblower Settlement
The case traces back to a whistleblower lawsuit filed by Jesse Allen, a former Capstone laboratory manager, under the False Claims Act's provisions allowing private citizens to sue on behalf of the government and collect a share of any recovered funds. That earlier action led to Capstone owner Andrew “Drew” Maloney pleading guilty in February 2024 to felony conspiracy to pay health care kickbacks, and Capstone reaching a $14.3 million civil settlement — from which Allen received an award of roughly $2.86 million, as Hoodline previously reported.
The federal government formally intervened in Allen's lawsuit on September 4, 2026, before filing the broader complaint against Johnson, Whiles, and the related corporate entities. Other co-conspirators connected to Capstone's kickback schemes have already pleaded guilty, including Dr. Duriel Gray, a licensed Georgia physician who served as medical director for a youth program and authorized Medicaid drug testing without examining participants, according to G2 Intelligence.
Criminal Charges Loom Alongside Civil Case
Johnson also faces separate, pending criminal charges tied to the alleged scheme. A federal grand jury in the Northern District of Georgia indicted him in December 2025 on charges of health care fraud, wire fraud, and conspiracy to pay and receive kickbacks, according to the Justice Department. Both the civil allegations and the criminal charges remain unproven in court.
The federal Anti-Kickback Statute makes offering, paying, soliciting, or receiving remuneration to induce referrals for federal health care items or services a felony punishable by up to 10 years in prison and fines up to $100,000 per violation, according to Lawsuit Legal. Separately, defendants found liable for submitting false Medicare claims under the False Claims Act face mandatory treble damages plus inflation-adjusted civil penalties ranging between $14,308 and $28,619 per false claim as of 2026, per the Health Law Alliance.
Part of a Record National Crackdown
The Atlanta case fits into a much larger pattern of federal health care fraud enforcement. In fiscal year 2025, the Department of Justice recovered an all-time record of $6.8 billion through False Claims Act enforcement actions nationwide, with health care fraud accounting for $5.7 billion of that total, according to HMTG Qui Tam Law. The U.S. Attorney's Office for the Northern District of Georgia provided details of the case through a press release announcing the lawsuit.
